In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Endius: Waiting for the Revolution in Spine

Executive Summary

Though tiny in a field dominated by huge companies, Endius believes it can hold sway in the niche of minimally invasive spine surgery, where it claims two key advantages: a single platform that enables spine surgeons to do 80% of the things they already do without changing open surgical techniques, and clinical advantages over open. Now Endius needs partnerships to gain complementary products for its access systems as well as relationships with surgeons. These allliances may not necessarily follow the traditional model of allying with a giant company for its distribution muscle. Endius might rather forge alliances with other small companies.

Related Content

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

IV002221

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel